GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Symbion Health Ltd (ASX:SY1) » Definitions » Beta

Symbion Health (ASX:SY1) Beta : N/A (As of Jun. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Symbion Health Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-21), Symbion Health's Beta is Not available.


Symbion Health Beta Historical Data

The historical data trend for Symbion Health's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Symbion Health Beta Chart

Symbion Health Annual Data
Trend Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Symbion Health Semi-Annual Data
Jun95 Jun96 Jun97 Jun98 Jun99 Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Symbion Health's Beta

For the Healthcare Plans subindustry, Symbion Health's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Symbion Health's Beta Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Symbion Health's Beta distribution charts can be found below:

* The bar in red indicates where Symbion Health's Beta falls into.



Symbion Health Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Symbion Health  (ASX:SY1) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Symbion Health Beta Related Terms

Thank you for viewing the detailed overview of Symbion Health's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Symbion Health (ASX:SY1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Symbion Group Limited (SYB, formerly Mayne Group Limited) is a healthcare-focused company comprised of 5 divisions: Pathology; Medical Centres; Imaging; Pharmacy Services; and Symbion Consumer.

Symbion Health (ASX:SY1) Headlines

No Headlines